Sociodemographic factors affecting the disease acceptance in the group of women with postmenopausal osteoporosis

Abstract

Objectives: Assessment of the disease acceptance level in women with osteoporosis depending on selected sociodemographic factors. Material and Methods: The study included a group of 198 women, aged M±SD 72.3±8.59 years, diagnosed with postmenopausal osteoporosis and treated in 2 Osteoporosis Treatment Centres in Łódź. A questionnaire survey and Acceptance of Illness Scale (AIS) were applied in the study. Based on the questionnaire, the authors collected sociodemographic data (including age, marital status, place of residence, financial status) which the authors subsequently analyzed using a statistical program. Results: The respondents living in the countryside, with primary education and a very difficult financial situation manifested a low disease acceptance level. The authors have shown that postmenopausal osteoporosis acceptance level significantly depends on the age (p = 0.0024), place of residence (p = 0.0044), education (p < 0.001) and affluence (p = 0.0049), however, it is not related to duration of the disease. Conclusions: Postmenopausal osteoporosis acceptance level depended on age, place of residence, education and affluence level, however, it was not related to the disease duration. Psychological aspects, including assessment according to the disease acceptance scale, constitute a factor influencing mental health, therefore they should be included in evaluation of therapy effectiveness in patients chronically treated for osteoporosis.

Causal roles of educational duration in bone mineral density and risk factors for osteoporosis: a Mendelian randomization study

“…They faced more barriers to implementing healthy practices and had less motivation for health [ 23 ]. A multicenter longitudinal study in Italy found a negative correlation between lower education level (45.8%) and body mass index(BMI) ( P = 0.013), smoking ( P < 0.001), and fractures ( P < 0.001) [ 18 ].…”

“…The WM method provided consistent effect estimates when at least 50% of the information in the analysis came from valid instruments. The heterogeneity was assessed using the Cochran’s Q test with the IVW method [ 18 ]. Heterogeneity was considered non-existent when the p -value of Cochran’s Q was > 0.05.…”

The prevalence and treatment rate trends of osteoporosis in postmenopausal women

“…Osteoporosis is associated with elevated risk of fracture, which has become a growing major public health problem, with an impact on quality and quantity of life that crosses medical, social, and economic lines [ 2 ]. There was evidence revealing that osteoporosis influenced more than 200 million people all over the world [ 3 ]. The disease is more common in women than in men and especially prevalent among postmenopausal women who experience a decline in levels of endogenous estrogens [ 4 ].…”

Resveratrol Prevents Apoptosis, allowing Preosteoblastic MC3T3-E1 cells to Proliferate and Differentiate

“…Górczewska and Jakubowska-Pietkiewicz, 2022). Res has been used to treat postmenopausal osteoporosis patients as an estrogen replacement therapy(Liu et al, 2021).…”